Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to $5.0 million.

  • Cross Country Healthcare's Other Working Capital Changes changed 0.0% to -$652000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year decrease of 13516.48%. This contributed to the annual value of $5.0 million for FY2024, which is 21416.15% up from last year.
  • Cross Country Healthcare's Other Working Capital Changes amounted to $5.0 million in FY2024, which was up 21416.15% from -$4.4 million recorded in FY2023.
  • In the past 5 years, Cross Country Healthcare's Other Working Capital Changes registered a high of $6.9 million during FY2022, and its lowest value of -$6.8 million during FY2021.
  • For the 5-year period, Cross Country Healthcare's Other Working Capital Changes averaged around -$1.0 million, with its median value being -$4.4 million (2023).
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first plummeted by 16321.04% in 2023, then surged by 21416.15% in 2024.
  • Cross Country Healthcare's Other Working Capital Changes (Annual) stood at -$5.9 million in 2020, then decreased by 15.0% to -$6.8 million in 2021, then surged by 202.4% to $6.9 million in 2022, then tumbled by 163.21% to -$4.4 million in 2023, then surged by 214.16% to $5.0 million in 2024.
  • Its Other Working Capital Changes stands at $5.0 million for FY2024, versus -$4.4 million for FY2023 and $6.9 million for FY2022.